Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3P27 is a pseudogene related to the BCL2 interacting protein 3 (BNIP3) gene. Unlike BNIP3, which codes for a protein involved in apoptosis, autophagy, and cell survival, BNIP3P27 does not code for a known protein and has no characterized functional role. The biologically relevant gene, BNIP3, is a member of the Bcl-2 family and plays important roles in cell death, autophagy, and resistance mechanisms in cancer. BNIP3P27 itself is not an established therapeutic target, biomarker, or modulator and is best considered an inactive or non-coding locus. The scientific literature focuses on BNIP3 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3), not on any BNIP3 pseudogenes, including BNIP3P27. All molecular functions, disease associations, and pharmacological interest apply to BNIP3, not BNIP3P27.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 27 (BNIP3P27).